Literature DB >> 20201881

The formation of the embryonic mouse heart: heart fields and myocardial cell lineages.

Yusuke Watanabe1, Margaret Buckingham.   

Abstract

During cardiogenesis in the mouse, the second heart field (SHF) is the source of the myocardium of the outflow tract and it contributes to other regions of the heart with the exception of the primitive left ventricle. This contribution corresponds with that of the second myocardial cell lineage, identified by retrospective clonal analysis. Gene regulatory networks, signaling pathways, and heterogeneity within the SHF are discussed, together with the question of regulation of myocardial progenitor cells within the first heart field. The extension of the SHF into the mesodermal core of the arches also gives rise to endothelial cells of the pharyngeal arch arteries. Knowledge about the origin and genetic regulation of cells that contribute to the heart and associated vasculature is important for the diagnosis and treatment of congenital heart malformations.

Entities:  

Mesh:

Year:  2010        PMID: 20201881     DOI: 10.1111/j.1749-6632.2009.05078.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  12 in total

1.  Wnt5a and Wnt11 are essential for second heart field progenitor development.

Authors:  Ethan David Cohen; Mayumi F Miller; Zichao Wang; Randall T Moon; Edward E Morrisey
Journal:  Development       Date:  2012-06       Impact factor: 6.868

Review 2.  Early cardiac development: a view from stem cells to embryos.

Authors:  Patrick Van Vliet; Sean M Wu; Stéphane Zaffran; Michel Pucéat
Journal:  Cardiovasc Res       Date:  2012-08-14       Impact factor: 10.787

3.  HoxBlinc RNA Recruits Set1/MLL Complexes to Activate Hox Gene Expression Patterns and Mesoderm Lineage Development.

Authors:  Changwang Deng; Ying Li; Lei Zhou; Joonseok Cho; Bhavita Patel; Naohiro Terada; Yangqiu Li; Jörg Bungert; Yi Qiu; Suming Huang
Journal:  Cell Rep       Date:  2015-12-24       Impact factor: 9.423

4.  VEGF-C and aortic cardiomyocytes guide coronary artery stem development.

Authors:  Heidi I Chen; Aruna Poduri; Harri Numi; Riikka Kivela; Pipsa Saharinen; Andrew S McKay; Brian Raftrey; Jared Churko; Xueying Tian; Bin Zhou; Joseph C Wu; Kari Alitalo; Kristy Red-Horse
Journal:  J Clin Invest       Date:  2014-10-01       Impact factor: 14.808

5.  The tissue-specific lncRNA Fendrr is an essential regulator of heart and body wall development in the mouse.

Authors:  Phillip Grote; Lars Wittler; David Hendrix; Frederic Koch; Sandra Währisch; Arica Beisaw; Karol Macura; Gaby Bläss; Manolis Kellis; Martin Werber; Bernhard G Herrmann
Journal:  Dev Cell       Date:  2013-01-28       Impact factor: 12.270

6.  Armadillo-like helical domain containing-4 is dynamically expressed in both the first and second heart fields.

Authors:  Simon J Conway; Reagan McConnell; Olga Simmons; Paige L Snider
Journal:  Gene Expr Patterns       Date:  2019-10-24       Impact factor: 1.224

7.  A HCN4+ cardiomyogenic progenitor derived from the first heart field and human pluripotent stem cells.

Authors:  Daniela Später; Monika K Abramczuk; Kristina Buac; Lior Zangi; Maxine W Stachel; Jonathan Clarke; Makoto Sahara; Andreas Ludwig; Kenneth R Chien
Journal:  Nat Cell Biol       Date:  2013-08-25       Impact factor: 28.824

Review 8.  Islet1-expressing cardiac progenitor cells: a comparison across species.

Authors:  Petra Pandur; Ioan Ovidiu Sirbu; Susanne J Kühl; Melanie Philipp; Michael Kühl
Journal:  Dev Genes Evol       Date:  2012-04-24       Impact factor: 0.900

9.  Transcription profiles of endothelial cells in the rat ductus arteriosus during a perinatal period.

Authors:  Norika Mengchia Liu; Tomohiro Yokota; Shun Maekawa; Ping Lü; Yun-Wen Zheng; Inbun Tei; Hideki Taniguchi; Utako Yokoyama; Takashi Kato; Susumu Minamisawa
Journal:  PLoS One       Date:  2013-09-27       Impact factor: 3.240

10.  TBX1 Represses Vegfr2 Gene Expression and Enhances the Cardiac Fate of VEGFR2+ Cells.

Authors:  Gabriella Lania; Rosa Ferrentino; Antonio Baldini
Journal:  PLoS One       Date:  2015-09-18       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.